Literature DB >> 12873265

The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain.

Steven D Passik1, Kenneth L Kirsh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12873265     DOI： 10.1046/j.1526-4637.2003.03018.x

Source DB:  PubMed          Journal:  Pain Med        ISSN： 1526-2375            Impact factor:   3.750


× No keyword cloud information.
  13 in total

1.  Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.

Authors:  Robert N Jamison; Edgar L Ross; Edward Michna; Li Q Chen; Caroline Holcomb; Ajay D Wasan
Journal:  Pain       Date:  2010-03-23       Impact factor: 6.961

Review 2.  Issues in long-term opioid therapy: unmet needs, risks, and solutions.

Authors:  Steven D Passik
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 3.  Adherence monitoring with chronic opioid therapy for persistent pain: a biopsychosocial-spiritual approach to mitigate risk.

Authors:  Deborah Matteliano; Barbara J St Marie; June Oliver; Candace Coggins
Journal:  Pain Manag Nurs       Date:  2012-10-23       Impact factor: 1.929

4.  Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.

Authors:  Kathryn Hawk; Gail D'Onofrio; David A Fiellin; Marek C Chawarski; Patrick G O'Connor; Patricia H Owens; Michael V Pantalon; Steven L Bernstein
Journal:  Acad Emerg Med       Date:  2017-12-26       Impact factor: 3.451

5.  Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy.

Authors:  Stephen F Butler; Simon H Budman; Gilbert J Fanciullo; Robert N Jamison
Journal:  Clin J Pain       Date:  2010 Nov-Dec       Impact factor: 3.442

6.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

7.  Development and validation of the Current Opioid Misuse Measure.

Authors:  Stephen F Butler; Simon H Budman; Kathrine C Fernandez; Brian Houle; Christine Benoit; Nathaniel Katz; Robert N Jamison
Journal:  Pain       Date:  2007-05-09       Impact factor: 6.961

8.  Using Analgesics for Emotional Modulation is Associated With Increased Distress, Depression, and Risk of Opioid and Alcohol Misuse: Initial Evaluation and Component Analysis of the Reasons for Analgesic Use Measure (RAUM).

Authors:  Kevin E Vowles; Robert W Bailey; Mindy L McEntee; Melissa Pielech; Karlyn A Edwards; Lena A Bolling; W Evan Rivers
Journal:  Clin J Pain       Date:  2018-10       Impact factor: 3.442

9.  Predictive variables of prescription opioid misuse in patients with chronic noncancer pain. Development of a risk detection scale: A registered report protocol.

Authors:  Carmen Ramírez-Maestre; Alicia E López-Martínez; Rosa Esteve
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

10.  Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication.

Authors:  Valentina Nikulina; Honoria Guarino; Michelle C Acosta; Lisa A Marsch; Cassandra Syckes; Sarah K Moore; Russell K Portenoy; Ricardo A Cruciani; Dennis C Turk; Andrew Rosenblum
Journal:  Pain       Date:  2016-08       Impact factor: 7.926
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.